Return to Listing

1 result(s) for Midostaurin (PKC412)

PI Name Protocol # Title
Richard Maziarz IRB00009571 A Phase II, Randomized Trial of Standard of Care with or without Midostaurin to Prevent Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with FLT3-ITD Mutated Acute Myeloid Leukemia

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080